Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase 2

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

pracinostat (SB939) / Helsinn, MEI, Menarini

NCT01112384: A Study of SB939 in Patients With Translocation-Associated Recurrent/Metastatic Sarcomas

Completed

Canada

SB939

NCIC Clinical Trials Group, S*BIO

Metastatic Sarcoma

01/13

01/14

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites